Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes.
about
Oxycodone for cancer-related painOxycodone for cancer-related painAbstral (Fentanyl Sublingual Tablets for Breakthrough Cancer Pain)Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative reviewPatient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastasesPain related to cancer treatments and diagnostic procedures: a no man's land?AAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsA systematic review: non-pharmacological interventions in treating pain in patients with advanced cancer.A Multi-centered Cross-sectional Study of Disease Burden of Pain of Inpatients in Southwest ChinaEffect of Music Therapy on Pain and Anxiety Levels of Cancer Patients: A Pilot Study.Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature.Prevalence of analgesic prescriptions among patients with cancer in Japan: an analysis of health insurance claims data.Psychological and behavioral approaches to cancer pain managementAcupuncture for the treatment of cancer pain: a systematic review of randomised clinical trials.Cancer Pain Management Insights and Reality in Southeast Asia: Expert Perspectives From Six Countries.Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled studyAssessing and treating pain in hospices: current state of evidence-based practicesAn evaluation of total disintegration time for three different doses of sublingual fentanyl tablets in patients with breakthrough painAttributes of cancer patients admitted to the emergency department in one year.Pain as a global public health priorityThe quality of pain management in German hospitals.The management of chronic pain in important patient subgroups.Development of dependence following treatment with opioid analgesics for pain relief: a systematic review.Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trialsRecent advances in the use of opioids for cancer painQuality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneCan a theory-based educational intervention change nurses' knowledge and attitudes concerning cancer pain management? A quasi-experimental designThe prevalence of pain in patients attending sarcoma outpatient clinics.Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate careSymptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer SurvivorsThe effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: a before-after cluster phase II trial.The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey).Developing effective cancer pain education programs.The prevalence of severe pain, its etiopathological characteristics and treatment profile of patients referred to a tertiary cancer care pain clinic.Rationale, design, and implementation protocol of the Dutch clinical practice guideline pain in patients with cancer: a cluster randomised controlled trial with Short Message Service (SMS) and Interactive Voice Response (IVR)Efficacy of an intrathecal multidrug infusion for pain control in older adults and in end-stage malignancies: A report of three cases.Association between patient-reported symptoms and nurses' clinical impressions in cancer patients admitted to an acute palliative care unit.CGRP 4218T/C polymorphism correlated with postoperative analgesic effect of fentanylUnresolved Pain Interference among Colorectal Cancer Survivors: Implications for Patient Care and Outcomes.
P2860
Q24187917-DA62B76C-F7AD-4860-AB7E-B73C1D143BF2Q24200369-E96B60C3-3618-46E5-BFBC-BA91AE1468B2Q24603566-40126648-B50B-4E7B-A05D-1145A231F737Q26744035-55227770-1EB8-4E1D-B2EB-4D9CA5B8794EQ26997330-01335082-2D76-42EB-817F-51CEBAD63D2EQ27026749-2B7FD70A-C0C1-4775-A40D-D0F4E3389FA0Q28079708-85B1FC84-766B-4DBA-923E-3ADDBFFCC9AAQ30361345-62F77713-C95E-4097-8F8C-B20EC6BC2914Q30385021-F5300C66-7354-49A7-8A87-66FDF64C3ADEQ30392215-F556E91A-DB25-4AAD-B733-277693942700Q30431143-CF14FFEA-D653-4E37-86AD-3DA934D10291Q30575838-B0768F9C-6F4E-49A9-A726-DA559AE02CA5Q33650569-F3EFAA85-A2E7-4F48-AA5E-80006B20B7BBQ33685487-72179332-99D4-4ACD-82D0-D8EDC0B5F0FEQ33872818-DFA4C2E2-2E0C-4FFA-9D79-445BA6329E2DQ33873528-1A5D55E5-DA25-49DC-BA00-7D33CBD5E2B6Q33910318-3EA30BF7-6829-4938-B42C-20234FA70980Q33938312-DBF76FEF-9C12-41DD-9491-8429D303C621Q34032373-F4828BEB-0379-422A-9908-4549252698BCQ34041898-F062D853-07FF-4763-80A6-A6ADC5A58D47Q34165284-3EBEFEA3-F610-4E18-B8C4-E9F5312F3CE4Q34326675-D8ACF19F-0FED-4D62-964A-E19E87B69E05Q34330919-A4063C13-DB95-4C70-9F56-B7D971CD8BA9Q34411964-E45036A2-9150-4174-9A40-1E7322FFD3B9Q34418203-3F0F4145-3C09-49EA-AB01-8F2C45D33E46Q34798408-E8FB9091-91B7-4CB4-9A58-E607E5414321Q34956657-D770C66F-D6CF-4003-905F-C76B64502956Q35013309-FF35DA50-0F2A-4DB5-AE66-8F4AE1ECABF3Q35028902-157EA10F-D158-4509-9E8C-F6D8D0462405Q35074737-D1933458-1466-45DB-A1E8-3A2292B840DDQ35128042-284DB29D-1C24-40B7-98C6-DC87D0C902ACQ35134363-AEA9CACC-D21F-4871-9916-F96048A2D274Q35277965-1EEFFADC-FAFB-4AFD-9CCB-CC99B54D6646Q35527081-948218D3-6D36-4C32-B65F-C571C1C44BFBQ35635953-9A1F826A-7293-4413-BB09-AE933CC772FEQ35642766-195DDF48-4AA5-4307-9E1D-2B0E886A7D84Q35659767-4A11B458-A713-465B-BA4D-F25DEE93384AQ35809381-00E77939-DC34-4517-B24E-5818984E4A0CQ35854383-13952DF6-093B-4F16-A7F8-4A7CD0E01C9BQ35858566-C3372222-463F-4AD4-BEB9-1EB17F0E6BCD
P2860
Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@en
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@nl
type
label
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@en
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@nl
prefLabel
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@en
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@nl
P2093
P2860
P356
P1433
P1476
Cancer-related pain: a pan-Eur ...... atment, and patient attitudes.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDP001
P577
2009-02-24T00:00:00Z